Authors


Petra Nitschke, Biopharma Insights Contributor, Business Development CEVEC Pharmaceuticals GmbH

Latest:

ELEVECTA® - The Next Level in Gene Therapy AAV Production

Introduction of ELEVECTA®, CEVEC’s fully scalable and stable production platform for AAV gene therapy viral vector manufacturing.



Shamik Sharma

Latest:

Fermentation Process Technology Transfer for Production of a Recombinant Vaccine Component

The authors describe challenges faced in transfer and scale-up of a fermentation process.


Dave Agrella

Latest:

Weighing Clinical Trial Outsourcing Options

Evolving clinical trial research services give biopharmaceutical companies options for full and functional services.


Allen Basis

Latest:

Change and Innovation

BioPharm International is the longest-running peer-reviewed publication dedicated to your work.


Brian Trdina

Latest:

Supplier-Change Management for Drug-Product Manufacturers

An effective supplier-initiated change management process is discussed.


Allison Whalley

Latest:

Fermentation Process Technology Transfer for Production of a Recombinant Vaccine Component

The authors describe challenges faced in transfer and scale-up of a fermentation process.


C. Richard

Latest:

Comparing Fed-Batch Cell Culture Performances of Stainless Steel and Disposable Bioreactors

A case study to compare the performances of several types of mixing in disposable bags with stainless steel bioreactors.


Oskar Gold

Latest:

Insourcing vs Outsourcing: Choosing the Right Strategy

The article reviews strategies for firms with or without existing in-house capacities and the pros and cons for outsourcing bio/pharmaceutical development and manufacturing.


Scott Maisto

Latest:

Weighing Clinical Trial Outsourcing Options

Evolving clinical trial research services give biopharmaceutical companies options for full and functional services.



Sushil Abraham

Latest:

Practical Considerations for Demonstrating Drug Substance Uniformity

The authors describe considerations and best practices for meeting drug substance uniformity.


L. Valognes

Latest:

Comparing Fed-Batch Cell Culture Performances of Stainless Steel and Disposable Bioreactors

A case study to compare the performances of several types of mixing in disposable bags with stainless steel bioreactors.


Melissa Germain

Latest:

Thermal Protection for Control-Room-Temperature Products

The authors discuss how to develop a cost-effective thermally protective packaging system.


Andrew J. Sheldon

Latest:

Plants As an Innovative and Accelerated Vaccine-Manufacturing Solution

A plant-based expression system could provide greater speed and capacity at a comparatively low cost.


William G. Whitford

Latest:

The Potential Application of Hollow Fiber Bioreactors to Large-Scale Production

A hollow fiber matrix allows for efficient harvest of secreted proteins.


R. Trieau

Latest:

Comparing Fed-Batch Cell Culture Performances of Stainless Steel and Disposable Bioreactors

A case study to compare the performances of several types of mixing in disposable bags with stainless steel bioreactors.


Rahul Parikh

Latest:

High-Throughput Multi-Product Liquid Chromatography for Characterization of Monoclonal Antibodies

These new analytical methods can reduce analysis and product development time.


Mark Tomai

Latest:

Optimizing a Unique Cancer Vaccine for Intradermal Delivery

Using a hollow microstructured transdermal system to deliver vaccine directly to the dermis.



Sophie LePage

Latest:

Sponsor-CMO Conflict Management for Clinical-Phase Biologics

The authors present the CMO's perspective on various potential sources of sponsor-CMO conflicts.



Vijesh Kumar

Latest:

Evolution of the Monoclonal Antibody Purification Platform

The authors discuss the evolution of the purification platform for manufacturing of mAb therapeutics.


Mike Gamble

Latest:

The Case for Insourcing

Why this workforce trend is well-suited for pharmaceutical companies.


Christina Satterwhite, PhD

Latest:

Assessing Development Needs for Biobetters and Biosimilars

Development requirements and regulatory guidance for biosimilars and biobetters.


Catherine Blake

Latest:

Automated Concentration and Diafiltration of Multiple siRNA Samples

Project: transfer a manual concentration/diafiltration process for siRNA production.


Trent Carrier

Latest:

Key Considerations When Outsourcing Cell-Culture Medium Development

The authors examine several issues that will help streamline negotiations between a service provider and a cell-culture medium consumer.



Vikram Sadineni

Latest:

Implications of Trace Levels of Redox-Active Metals in Drug-Product Formulation

The presence of minute amounts of chelators can help minimize the degradation of monoclonal antibodies.


© 2025 MJH Life Sciences

All rights reserved.